Growth Metrics

Nephros (NEPH) Income from Continuing Operations (2010 - 2026)

Nephros' quarterly Income from Continuing Operations came in at 129000.0 in Q1 2026, down 77.72% year-on-year from 579000.0 in Q1 2025, and up 108.06% quarter-over-quarter from 62000.0 in Q4 2025.

Nephros has reported Income from Continuing Operations for 17 years, with the latest figure at 129000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations fell 77.72% year-over-year to 129000.0; the trailing twelve-month figure through Mar 2026 stood at 765000.0 (down 8.6% YoY), and the FY2025 full-year result was 1194000.0, up 1513.51% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 129000.0, up from 62000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 579000.0 in Q1 2025, with the low at 1554000.0 in Q1 2022.
  • Average Income from Continuing Operations over 5 years is 261647.06, with a median of 192000.0 recorded in 2023.
  • Peak annual rise in Income from Continuing Operations reached 428.98% in 2025, while the deepest fall reached 82.97% in 2025.
  • Tracing NEPH's Income from Continuing Operations over 5 years: stood at 689000.0 in 2022, then increased by 9.72% to 622000.0 in 2023, then soared by 158.52% to 364000.0 in 2024, then tumbled by 82.97% to 62000.0 in 2025, then surged by 108.06% to 129000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 129000.0 (Q1 2026), 62000.0 (Q4 2025), and 337000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -37.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 398.73 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 135.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 13.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 130.80 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 112.77 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -17.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 72.77 Mn
10 Nephros 38.93 Mn 34.91 Mn 2.99 Mn 129,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 129,000.00
Dec 31, 2025 62,000.00
Sep 30, 2025 337,000.00
Jun 30, 2025 237,000.00
Mar 31, 2025 579,000.00
Dec 31, 2024 364,000.00
Sep 30, 2024 183,000.00
Jun 30, 2024 -289,000.00
Mar 31, 2024 -176,000.00
Dec 31, 2023 -622,000.00
Sep 30, 2023 -192,000.00
Jun 30, 2023 -422,000.00
Mar 31, 2023 -295,000.00
Dec 31, 2022 -689,000.00
Sep 30, 2022 -1.28 Mn
Jun 30, 2022 -819,000.00
Mar 31, 2022 -1.55 Mn
Dec 31, 2021 -726,000.00
Sep 30, 2021 -810,000.00
Jun 30, 2021 -1.13 Mn
Mar 31, 2021 -1.03 Mn
Dec 31, 2020 -731,000.00
Sep 30, 2020 -951,000.00
Jun 30, 2020 -1.62 Mn
Mar 31, 2020 -1.07 Mn
Dec 31, 2019 -346,000.00
Sep 30, 2019 -743,000.00
Jun 30, 2019 -914,000.00
Mar 31, 2019 -1.35 Mn
Dec 31, 2018 -754,000.00
Sep 30, 2018 -542,000.00
Jun 30, 2018 -680,000.00
Mar 31, 2018 -1.21 Mn
Dec 31, 2017 -486,000.00
Sep 30, 2017 -605,000.00
Jun 30, 2017 -763,000.00
Mar 31, 2017 -670,000.00
Dec 31, 2016 -671,000.00
Sep 30, 2016 -701,000.00
Jun 30, 2016 -846,000.00
Mar 31, 2016 -819,000.00
Dec 31, 2015 -948,000.00
Sep 30, 2015 -1.10 Mn
Jun 30, 2015 -603,000.00
Mar 31, 2015 -817,000.00
Dec 31, 2014 -996,000.00
Sep 30, 2014 -746,000.00
Jun 30, 2014 -653,000.00
Mar 31, 2014 -757,000.00
Dec 31, 2013 -1.17 Mn
Sep 30, 2013 -613,000.00
Jun 30, 2013 -652,000.00
Mar 31, 2013 -1.03 Mn
Dec 31, 2012 -1.11 Mn
Sep 30, 2012 -853,000.00
Jun 30, 2012 -811,000.00
Mar 31, 2012 -555,000.00
Dec 31, 2011 -640,000.00
Sep 30, 2011 -423,000.00
Jun 30, 2011 -597,000.00
Mar 31, 2011 -658,000.00
Dec 31, 2010 -604,000.00
Sep 30, 2010 -393,000.00
Jun 30, 2010 -365,000.00